Classification Information
therapeutic preparations for the treatment of respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19; therapeutic preparations, namely, antibodies for the purpose of targeting the CCR5 cell receptor of cells and inhibiting or blocking the channel signaling of the CCR5 cell receptor for medical treatment
Pharmaceuticals